BANK OF AMERICA CORP /DE/ - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 99 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$9,008,000
-44.0%
376,892
-65.8%
0.00%
-50.0%
Q4 2020$16,098,000
+5.3%
1,102,626
+2.4%
0.00%0.0%
Q3 2020$15,292,000
+1.8%
1,076,879
+5.5%
0.00%0.0%
Q2 2020$15,018,000
+30.7%
1,020,991
-63.4%
0.00%0.0%
Q1 2020$11,492,000
+14.0%
2,789,469
+33.1%
0.00%
+100.0%
Q4 2019$10,082,000
-0.4%
2,096,219
+25.5%
0.00%
-50.0%
Q3 2019$10,123,000
+3.0%
1,670,328
+10.3%
0.00%
+100.0%
Q2 2019$9,825,000
+1.8%
1,513,795
+11.2%
0.00%0.0%
Q1 2019$9,653,000
+65.1%
1,361,547
+13.1%
0.00%0.0%
Q4 2018$5,848,000
-19.9%
1,203,510
+21.2%
0.00%0.0%
Q3 2018$7,301,000
+25.8%
993,339
+9.2%
0.00%0.0%
Q2 2018$5,802,000
+16.7%
909,431
-0.5%
0.00%0.0%
Q1 2018$4,970,000
+37.9%
913,625
+5.7%
0.00%0.0%
Q4 2017$3,603,000
+25.4%
864,208
+189.6%
0.00%
Q3 2017$2,874,000
+20428.6%
298,452
+23852.8%
0.00%
Q2 2017$14,000
-85.9%
1,246
-83.8%
0.00%
Q1 2017$99,000
-76.1%
7,714
-77.2%
0.00%
Q4 2016$414,000
+1700.0%
33,785
+1574.2%
0.00%
Q3 2016$23,000
-39.5%
2,018
-54.4%
0.00%
Q2 2016$38,000
-97.1%
4,430
-98.2%
0.00%
Q1 2016$1,306,000
-32.4%
247,850
-0.4%
0.00%
Q4 2015$1,931,000
-66.8%
248,870
-66.3%
0.00%
-100.0%
Q3 2015$5,809,000
-20.8%
738,169
-8.8%
0.00%
-50.0%
Q2 2015$7,331,000
-29.6%
809,172
+0.9%
0.00%
-50.0%
Q1 2015$10,407,000
-4.6%
801,763
+0.0%
0.00%0.0%
Q4 2014$10,909,000
+41.1%
801,578
-7.0%
0.00%
+33.3%
Q3 2014$7,731,000
-39.9%
861,904
-9.4%
0.00%
-25.0%
Q2 2014$12,866,000
+36.2%
950,884
+0.0%
0.00%0.0%
Q1 2014$9,448,000
-9.7%
950,464
+20.8%
0.00%0.0%
Q4 2013$10,461,000
+9.4%
787,106
-0.1%
0.00%0.0%
Q3 2013$9,561,000
+9.9%
787,624
-6.3%
0.00%0.0%
Q2 2013$8,701,000840,8680.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders